A detailed history of Citigroup Inc transactions in Spdr Ser Tr Spdr S&P Pharmaceu stock. As of the latest transaction made, Citigroup Inc holds 1 shares of XPH stock, worth $39. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 401 99.75%
Holding current value
$39
Previous $16,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$41.38 - $45.49 $16,552 - $18,196
-400 Reduced 99.75%
1 $0
Q2 2023

Aug 10, 2023

SELL
$39.1 - $42.57 $3,870 - $4,214
-99 Reduced 19.8%
401 $16,000
Q1 2023

May 11, 2023

BUY
$39.61 - $44.25 $3,961 - $4,425
100 Added 25.0%
500 $20,000
Q3 2022

Nov 10, 2022

SELL
N/A
-2,496 Reduced 86.19%
400 $16,000
Q2 2022

Aug 10, 2022

BUY
N/A
1,340 Added 86.12%
2,896 $122,000
Q1 2022

May 12, 2022

SELL
N/A
-98 Reduced 5.93%
1,556 $70,000
Q4 2021

Feb 10, 2022

SELL
N/A
-466 Reduced 21.98%
1,654 $76,000
Q3 2021

Nov 10, 2021

BUY
N/A
2,120 New
2,120 $101,000

Others Institutions Holding XPH

About SPDR SER TR SPDR S&P PHARMACEU


  • Ticker XPH
  • Sector ETFs
  • Industry ETFs
More about XPH
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.